References2

References

Abbott et al. Development of CRISPR as a Prophylactic Strategy to Combat Novel Coronavirus and Influenza, March 14, 2020, bioRxiv. https://doi.org/10.1101/2020.03.13.991307

Ahn et al. Unique Loss of the PYHIN Gene Family in Bats Amongst Mammals: Implications for Inflammasome Sensing. Sci Rep 6, 21722 (2016). https://doi.org/10.1038/srep21722

Ai et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology, February 26, 2020. https://doi.org/10.1148/radiol.2020200642

Amanat et al. A serologic assay to detect SARS-CoV-2 seroconversion in humans. MedRxiv, https://doi.org/10.1101/2020.03.17.20037713.

Alsoussi, W.B. et al. A potently neutralizing antibody protects mice against SARS-COV-2 infection. J. Immunol 205:915-922 (2020).

Ameri A, Rahnama N, Bozorgmehr R, et al. Low dose whole lung irradiation for COVID-19 pneumonia: short course results. Int J Rad Oncol Biol Phys (in press) https://doi.org/10.1016/j.ijrobp.2020.07.026

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, Fifty Edition. Arlington, VA, 2013. https://www.psychiatry.org/psychiatrists/practice/dsm

Amici et al. Indomethacin has a Potent Antiviral Activity Against SARS Coronavirus. Antivir Ther., 2006, 11(8): 1021-30. https://www.ncbi.nlm.nih.gov/pubmed/17302372

Anand, P., Puranik, A., Aravaduman, M., et al. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC. eLife, 2020. https://doi.org/10.7554/eLife.58603

Anderson et al. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. The New England Journal of Medicine, September 29, 2020. https://doi.org/10.1056/NEJMoa2028436

Arunachalam, P.S. et al. Systems biological assessment of immunity to mild versus severe COVID-19 infections in humans. Science, 2020.

Auld et al. ICU and Ventilator Mortality Among Critically Ill Adults with Coronavirus Disease 2019. Critical Care Medicine, March 26, 2020. https://doi.org/10.1097/CCM.0000000000004457

Axfors et al. Mortality Outcomes with Hydroxychloroquine and Chloroquine in COVID-19: An International Collaborative Meta-Analysis of Randomized Trials. MedRxiv, September 18, 2020. https://doi.org/10.1101/2020.09.16.20194571

Balsari, S., Buckee, C., Khanna, T. Which Covid-19 data can you trust? Harvard Business Review May 8, 2020. https://hbr.org/2020/05/which-covid-19-data-can-you-trust

Bailey, C., Black, J.R.M., Swanton, C. Cancer Research: The lessons to learn from COVID-19. Cancer Discovery, September 2020. https://doi.org/10.1158/2159-8290.CD-20-0823

Bancos et al. Ibuprofen and Other Widely Used Non-steroidal Anti-Inflammatory Drugs Inhibit Antibody Production in Human Cells. Cell Immunology, 2009, 258(1): 18-28.

https://doi.org/10.1016/j.cellimm.2009.03.007

Baranovich et al. T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro. Journal of Virology, 87(7): 3741-3751, April 2013. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624194/

Baratchian, M., McManus, J., Berk, M., et al. No evidence than androgen regulation of pulmonary YMPRSS2 explains sex-discordant COVID-19 outcomes. bioRxiv (2020) https://doi.org/10.1101/2020.04.21.051201

Barreca, A., Shimshack, J. Absolute Humidity, Temperature, and Influenza Mortality: 30 Years of County-Level Evidence from the United States. American Journal of Epidemiology, 176 Supplement 7: S114-22, October 2012. https://doi.org/10.1093/aje/kws259

Basu et al. Performance of the Rapid Nucleic Amplification by Abbott ID NOW COVID-19 in Nasopharyngeal Swabs Transported in Viral Media and Dry Nasal Swabs, in a New York City Academic Institution. BioRxiv, May 12, 2020. https://doi.org/10.1101/2020.05.11.089896

Baum et al. Antibody Cocktail to SARS-CoV-2 Spike Protein Prevents Rapid Mutational Escape Seen with Individual Antibodies. Science, August 21, 2020. https://doi.org/10.1126/science.abd0831

Baum et al. REGN-CoV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus monkeys and hamsters. Science, 2020. https://doi.org/10.1126/science.abe2402

Beigel, J.H., Tomashek, K.M., Dodd, L.E., et al. Remdesevir for the treatment of Covid-19 – Preliminary report. NEJM DOI: 10.1056/NEJMoa200764.

Belyi et al. Electrostatic Origin of the Genome Packaging in Viruses. Proceedings of the National Academy of Sciences U.S.A., Nov. 14, 2006; 103(46):17174-8. https://doi.org/10.1073/pnas.0608311103

Bendavid et al. COVID-19 Antibody Seroprevalence in Santa Clara County, California. MedRxiv, April 17, 2020. https://doi.org/10.1101/2020.04.14.20062463

Berkley, S. COVID-19 needs a Manhattan Project, Science, 2020.

Besedovsky et al. Sleep and Immune Function. European Journal of Physiology, 2012, 463: 121-137.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256323/pdf/424_2011_Article_1044.pdf

Blanco-Melo et al. Imbalanced Host Cell Response to SARS-CoV-2 Drives Development of COVID-19. Cell, May 15, 2020. https://doi.org/10.1016/j.cell.2020.04.026

Bonanno, G.A., Gupta, S. 2009. Resilience after disaster. In Neria Y, Galea S, Norris FH, eds. 2009. Mental Health and Disasters. New York: Cambridge Univ. Press, pp. 145–60. https://www.cambridge.org/core/books/mental-health-and-disasters/B7260C9227B3D1E44AB59AE4CA7DE1B0

Borba et al. Chloroquine Diphosphate in Two Different Dosages as Adjunctive Therapy of Hospitalized Patients with Severe Respiratory Syndrome in the Context of Coronavirus (SARS-CoV-2) Infection: Preliminary Safety Results of a Randomized, Double-Blinded, Phase IIb Clinical Trial (ChloroCid-19 Study), April 11, 2020. MedRxiv. https://doi.org/10.1101/2020.04.07.20056424

Borno HT, Small EJ. Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research? Contemporary Clinical Trials 92: (2020). https://doi.org/10.1016/j.cct.2020.105997

Borrell. New York Clinical Trial Quietly Tests Heartburn Remedy Against Coronavirus. Science, April 26, 2020. doi:10.1126/science.abc4739

Bouhaddou M et al., The global phosphorylation landscape of SARS-CoV-2 infection. Cell 182:1-28, 2020.

Bourouib, Lydia. Turbulent Gas Clouds and Respiratory Pathogen Emissions. JAMA Insights, March 26, 2020; 323(18):1837-1838. https://jamanetwork.com/journals/jama/fullarticle/2763852

Brainard J. New tools aim to tame pandemic paper tsunami. Science 368:924-925 (2020).

Brandt, A.M. and Botelho, A. Not a perfect storm – Covid-19 and the importance of language. New England J Med 382:1493-1495 (2020).

Breslin, N., Baptiste, C., Gyamfi-Banneman, C., et al. COVID-19 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM.2020. https://www.ncbi.nlm.nih.gov/pubmed/32292903

Britton et al. A Mathematical Model Reveals the Influence of Population Heterogeneity on Herd Immunity to SARS-CoV-2. Science, August 14, 2020. https://doi.org/10.1126/science.abc6810

Broughton et al. CRISPR-Cas12-Based Detections of SARS-CoV-2. Nature Biotechnology, April 16 2020. https://doi.org/10.1038/s41587-020-0513-4

Buonanno et al. Far-UVC Light Efficiently and Safely Inactivates Airborne Human Coronaviruses. Virology pre-print, under review, April 27, 2020. https://doi.org/10.21203/rs.3.rs-25728/v1

Caly et al. The FDA-Approved Drug Ivermectin Inhibits the Replication of SARS-CoV-2 in Vitro. Antiviral Research, April 3 2020. https://doi.org/10.1016/j.antiviral.2020.104787

Cameron et al. Preliminary Evidence that Higher Temperatures are Associated with Lower Incidence of COVID-19, for Cases Reported Globally up to 29th February 2020. March 2020. https://doi.org/10.1101/2020.03.18.20036731

Candelario, K.M. and Steindler, D.A., The role of extracellular vesicles in the progression of neurodegenerative disease and cancer. Trends Mol Med, 2014.

Candelario, K.M. et al., Exosome/Microvesicle content is altered in LRRK2 mutant iPS-derived neural cells. J. Comp Neurol, 2020.

Cannell et al. Epidemic Influenza and Vitamin D. Epidemiology & Infection, 2006, 134(6): 1129-1140.

https://doi.org/10.1017/S0950268806007175

Cao et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. New England Journal of Medicine, March 18, 2010. https://www.nejm.org/doi/full/10.1056/NEJMoa2001282

Cao, L. et al. De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science 10.1126/science.abd9909 (2020).

Carlucci et al. Hydroxychloroquine and Azithromycin Plus Zinc vs. Hydroxychloroquine and Azithromycin Alone: Outcomes in Hospitalized COVID-19 Patients. MedRxiv, May 8, 2020. https://doi.org/10.1101/2020.05.02.20080036

Centers for Disease Control and Prevention. Interim considerations for infection prevention and control of coronavirus disease 2019 (COVID-19) in inpatient obstetric healthcare settings (2020)

https://www.cdc.gov/coronavirus/2019-ncov/hcp/inpatient-obstetric-guidance-healthcare.html

Centers for Disease Control and Prevention. Interim guidance for use of pooling procedures in SARS-Cov-2 Diagnostic, screening, and surveillance testing. Updated 1 August, 2020 (accessed 16 October, 2020).

Chandrashekar et al. SARS-CoV-2 Infection Protects Against Rechallenge in Rhesus Macaques. Science, May 20, 2020. https://doi.org/10.1126/science.abc4776

Chang et al. The SARS Coronavirus Nucleocapsid Protein -- Forms and Functions. Antiviral Research, March 2014. https://doi.org/10.1016/j.antiviral.2013.12.009

Chen et al. A Pilot Study of Hydroxychloroquine in Treatment of Patients with Common Coronavirus Disease-19 (COVID-19). Journal of Zhejiang University, March 2020.

http://subject.med.wanfangdata.com.cn/UpLoad/Files/202003/43f8625d4dc74e42bbcf24795de1c77c.pdf

Chen, W. et al. SARS-associated Coronavirus Transmitted from Human to Pig. Emerging Infectious Diseases, March 2005; 11(3):446-448. https://doi.org/10.3201/eid1103.040824

Chen, Z. et al. Efficacy of Hydroxychloroquine in Patients with COVID-19: Results of a Randomized Clinical Trial. MedRxiv, April 10, 2020. https://doi.org/10.1101/2020.03.22.20040758

Chevalier et al. Massively parallel de novo protein design for targeted therapeutics. Nature 550:74-79 (2017). https://doi.org/10.1038/nature23912

Chin et al. Stability of SARS-CoV-2 in Different Environmental Conditions. The Lancet Microbe, April 2, 2020. https://doi.org/10.1016/S2666-5247(20)30003-3

Chou, R., Pappas, M., Buckley, D., et al. Use of chest imaging in COVID-19 a rapid advice guide. World Health Organization. WHO-2019-nCoV-Clinical-Radiology_imaging-Web_Annex_A-2020.1-eng

Cohen, J. Russia’s Approval of a COVID-19 Vaccine is Less than Meets the Press Release. Science, August 11, 2020. https://doi.org/10.1126/science.abe2848

Complaint, State v. Stine, No. 20-2-09935-0 SEA (Wash. Super. Ct. June 12, 2020), https://agportal-s3bucket.s3.amazonaws.com/2020_06_12Complaint.pdf.

Consiglio et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell 183:1-14, 2020. https://doi.org/10.1016/j.cell.2020.09.016

Corey, L., Mascola, J.R., Fauci, A.S. and F.S. Collins. A strategic approach to COVID-19 vaccine R&D. Science, 2020.

CoroNope, CoroNope: A Crowdsourced SARS-CoV-2 Vaccine (2020), https://siasky.net/bACLKGmcmX4NCp47WwOOJf0lU666VLeT5HRWpWVtqZPjEA.

Cortillez-Ty et al. Severe Acute Respiratory Syndrome Nonstructural Protein 2 Interacts with a Host Protein Complex Involved in Mitochondrial Biogenesis and Intracellular Signalling. Journal of Virology, September 2009. https://doi.org/10.1128/JVI.00842-09

Coutard et al. The Spike Glycoprotein of the New Coronavirus 2019-nCoV Contains a Furin-Like Cleavage Site Absent in CoV of the Same Clade. Antiviral Research, April 2020, 176, 104742. https://doi.org/10.1016/j.antiviral.2020.104742

Crotty et al. Immunological Memory to SARS-CoV-2 Assessed for Greater than Six Months After Infection. BioRxiv. November 16, 2020. https://doi.org/10.1101/2020.11.15.383323

Dai M., Liu D., Liu M., et al. Patients with cancer appear to be more vulnerable to SARS-COV-2: A multi-center study during the COVID-19 outbreak. cancerdiscovery.aacrjournals.org April, 2020

Dai W., Zhang B., Jiang X.-M., et al. Structure based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science 368:1331-1335 (2020).

Daneshkhah et al. The Possible Role of Vitamin D in Suppressing Cytokine Storm and Associated Mortality in COVID-19 Patients. MedRxiv, April 30, 2020. https://doi.org/10.1101/2020.04.08.20058578

De Clercq et al. Therapeutic Options for the 2019 Novel Coronavirus (2019-nCoV), Nature Reviews Drug Discovery, February 10, 2020. https://www.nature.com/articles/d41573-020-00016-0

de Vries et al., Intranasal fusion inhibitory lipopeptide prevents direct SARS-CoV-2 transmission in ferrets. bioRxiv, 2020.

Deng, W et al., Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science, 369:818, August 14, 2020

Diao et al. Reduction and Functional Exhaustions of T Cells in Patients with Coronavirus Disease 2019. MedRxiv. February 20, 2020. https://doi.org/10.1101/2020.02.18.20024364.

Dinnon et al. A mouse-adapted SARS-CoV-2 model for the evaluation of medical countermeasures. bioRxiv, 2020. https://doi.org/10.1101/2020.05.06.081497

Dou et al. De novo design of a fluorescence-activating beta-barrel. Nature 561:485-491 (2018) https://doi.org/10.1038/s41586-018-0509-0

Duan et al. Effectiveness of Convalescent Plasma Therapy in Severe Covid-19 Patients. Proceedings of the National Academy of Sciences of the United States of America, April 6, 2020.

https://doi.org/10.1073/pnas.2004168117

Dyal et al. COVID-19 Among Workers in Meat and Poultry Processing Plants Facilities - 19 States, April 2020. Morbidity and Mortality Weekly Report, May 8, 2020; 69(18): 557-561. http://dx.doi.org/10.15585/mmwr.mm6918e3

Ellinghaus et al. Genomewide Association Study of Severe COVID-19 with Respiratory Failure. The New England Journal of Medicine, June 17, 2020. https://www.nejm.org/doi/full/10.1056/NEJMoa2020283

Endo et al. Estimating the Overdispersion in COVID-19 Transmission Using Outbreak Sizes Outside China. Wellcome Open Research, 2020; 5:67. https://doi.org/10.12688/wellcomeopenres.15842.1

Escher et al. Severe COVID-19 Infection Associated with Endothelial Activation. Thrombosis Research, April 13, 2020. https://doi.org/10.1016/j.thromres.2020.04.014

Estep et al. for the Rapid Deployment Vaccine Collaborative (RaDVaC). SARS-CoV-2 (2019-nCoV).

Fang, L. et al. Are Patients with Hypertension and Diabetes Mellitus at Increased Risk for COVID-19 Infection? Lancet Respiratory Medicine, March 11, 2020. https://doi.org/10.1016/S2213-2600(20)30116-8

Fang, Y. et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology, February 19, 2020. https://doi.org/10.1148/radiol.2020200432

Fehr, A.R., Perlman S. (2015) Coronaviruses: An Overview of Their Replication and Pathogenesis. In: Maier H., Bickerton E., Britton P. (eds) Coronaviruses. Methods in Molecular Biology, vol 1282. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2438-7_1

Filippi, A.R., Russi, E., Magrini, S.M., Corvò, R. COVID-19 Outbreak in Northern Italy: First Practical Indications for Radiotherapy Departments, International Journal of Radiation Oncology (2020) https://doi.org/10.1016/ j.ijrobp.2020.03.007

Fischer et al. Low-Cost Measurement of Facemask Efficacy for Filtering Expelled Droplets During Speech. Science Advances, August 7, 2020: https://doi.org/10.1126/sciadv.abd3083

Fischhoff et al. Using the Psychological Science of Crisis Leadership and Communications to Navigate the Coronavirus: A Webinar for Public Officials (2020)

https://www.apa.org/practice/programs/dmhi/research-information/covid-19-webinar-pubic-officials.pdf

Fogarty A, et al. Pooled saliva samples for COVID-19 surveillance program. The Lancet (2020) . https://doi.org/10.1016/S2213-2600(20)30444-6

Folegatti et al. Safety and Immunogenicity of the ChadOx1 nCoV-2019 Vaccine Against SARS-CoV-2: A Preliminary Report of a Phase I/II, Single-Blind, Randomised Controlled Trial. The Lancet, August 15, 2020, 396(10249): 467-478. https://doi.org/10.1016/S0140-6736(20)31604-4

Foley et al. Growing Old, Yet Staying Young: The Role of Telomeres in Bats’ Exceptional Longevity. Science Advances, February 7, 2018, 4(2). https://advances.sciencemag.org/content/4/2/eaao0926

Forrey et al. Electrostatics of Capsid-Induced Viral RNA Organization. The Journal of Chemical Physics, September 14, 2009; 131(10): 105101. https://doi.org/10.1063/1.3216550

Forster et al. Phylogenetic Network Analysis of SARS-CoV-2 Genomes. Proceedings of the National Academy of Sciences of the United States of America, April 8, 2020.

https://doi.org/10.1073/pnas.2004999117

Freedberg et al. Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Study. MedRxiv, May 8, 2020. https://doi.org/10.1101/2020.05.01.20086694

Frontera J et al. A prospective study of neurologic disorders in hospitalized COVID-19 patients in New York. Neurology, 2020.

Furuta et al. T-705 (Favipiravir) and Related Compounds: Novel Broad-spectrum Inhibitors of RNA Viral Infections. Antiviral Research, 82(3): 95-102, June 2009.

https://doi.org/10.1016/j.antiviral.2009.02.198

Gautret, P., Lagier, J.-C., Parola, P. et al. Clinical and Microbiological Effect of a Combination of Hydroxychloroquine and Azithromycin in 80 COVID-19 patients with at least a six-day follow up: an observational study. March 2020. International Journal of Antimicrobial Agents.

https://doi.org/10.1016/j.ijantimicag.2020.105949

Galano et al. On the Free Radical Scavenging Activities of Melatonin’s Metabolites, AFMK and AFK. Journal of Pineal Research, April 2013, 54(3): 245-257. https://doi.org/10.1111/jpi.12010

Ghinai, I. et al., First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA, the Lancet, 395 10230 P1137-1144 April 4, 2020

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30607-3/fulltext

Goldberg, P. Class of drugs used to treat CAR T-cell toxicity may reduce COVID-19 deaths. The Cancer Letter March 27, 2020

Goldman, E. and Galea, S. The Mental Health Consequences of Disasters. Annual Review of Public Health Vol. 35: 169-183, March, 2014.

https://www.annualreviews.org/doi/full/10.1146/annurev-publhealth-032013-182435

Gordon et al. A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing. bioRxiv. https://doi.org/10.1101/2020.03.22.002386.

Graham et al. Evaluation of the Immunogenicity of Prime-Boost Vaccination with the Replication-Deficient Viral Vectored COVID-19 Vaccine Candidate ChadOx1 nCoV-2019. bioRxiv, June 20, 2020. https://doi.org/10.1101/2020.06.20.159715

Grein et al. Compassionate Use of Remdesivir for Patients with Severe COVID-19. The New England Journal of Medicine, April 10, 2020. https://doi.org/10.1056/NEJMoa2007016

Grifoni et al. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2. Cell Host & Microbe, March 16, 2020. https://doi.org/10.1016/j.chom.2020.03.002

Grifoni et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell, June 25, 2020. 181: 1489-1501.

Gu, H. et al. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine therapy. Science, 369: 1603-1607, 2020. https://doi.org/10.1126/science.abc4730

Guérin et al. Prone Positioning in Severe Acute Respiratory Distress Syndrome. New England Journal of Medicine, 2013; 368:2159-2168. https://www.nejm.org/doi/full/10.1056/NEJMoa1214103

Guerrini et al. Self–experimentation, ethics, and regulation of vaccines. Science 369:1570-1572 (2020). https://doi.org/10.1126/science.abe1963

Guo et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clinical Infectious Diseases, March 21, 2020. https://doi.org/10.1093/cid/ciaa310

Hansen J, et al. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science 369:1010, August 21, 2020. https://doi.org/10.1126/science.abd0827

Hao Yao, H., Chen, J., and Yi-Feng, X. Patients with mental health disorders in the COVID-19 epidemic. The Lancet. Volume 7, Issue 4, Pe21, April 01, 2020 https://doi.org/10.1016/S2215-0366(20)30090-0

Haschke et al. Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects. Clinical Pharmacokinetics. September 2013; 52: 783-792. https://doi.org/10.1007/s40262-013-0072-7

Hellerstein, M. What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2? Vaccine: X 6 (2020) 100076 https://doi.org/10.1016/j.jvacx.2020.100076

Herold et al. Levels of IL-6 Predicts Respiratory Failure in Hospitalized Symptomatic COVID-19 Patients. MedRxiv: https://doi.org/10.1101/2020.04.01.20047381

Hess, C.B., Buchwald, Z.S., Stokes, W. et al. Low-dose whole-lung radiation for COVID-19 pneumonia: Planned Day-7 interim analysis of an ongoing clinical trial. MedRxiv doi:https://doi.org/10.1101/2020.06.03.20116988

Hoffmann et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, https://doi.org/10.1016/j.cell.2020.02.052 Cell 181:2020

Holshue et al. First Case of 2019 Novel Coronavirus in the United States. The New England Journal of Medicine 2020, 382: 929-936. https://www.nejm.org/doi/10.1056/NEJMoa2001191

Horby et al. Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary Results from a Multi-Centre, Randomized, Clinical Trial. MedRxiv, July 15, 2020. https://doi.org/10.1101/2020.07.15.20151852

Horton R. Offline: Science and the breakdown of trust. The Lancet 396:945 (2020). https://doi.org/10.1016/S0140-6736(20)32064-X

Huang, A. et al. A Systematic Review of Antibody Mediated Immunity to Coronaviruses: Antibody Kinetics, Correlates of Protection, and Association of Antibody Responses with Severity of Disease. MedRxiv, April 17, 2020. https://doi.org/10.1101/2020.04.14.20065771

Huang, C. et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet February 15, 2020, 395(10223): p. 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5

Imai et al. Angiotensin-converting Enzyme 2 Protects from Severe Acute Lung Failure. Nature 2005, 436(7047): 112-116. https://www.nature.com/articles/nature03712

Isho et al. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients. Science Immunology, October 8, 2020. https://doi.org/10.1126/sciimmunol.abe5511

Iyer et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 in COVID-19 patients. Science Immun., 2020. https://doi.org/10.1126/sciimmunol.abe0367

Jackson et al. An mRNA Vaccine Against SARS-CoV-2–Preliminary Report. The New England Journal of Medicine, July 14, 2020. https://www.nejm.org/doi/full/10.1056/NEJMoa2022483

Jaimes, J.A., Millet, J.K., and Whittaker, G.R. Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site. iSCIENCE (2020), doi: https://doi.org/10.1016/j.isci.2020.101212

Jin, Z. et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature https://doi.org/10.1038/s41586-020-2223-y (2019)

Johnson, K. Brutal plan to restrict palliative radiotherapy during pandemic. MedScape Oncology (2020).

Joyner et al. Early Safety Indicators of COVID-19 Convalescent Plasma in 5,000 Patients. MedRxiv, May 14, 2020. https://doi.org/10.1101/2020.05.12.20099879

Joyner et al. Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience. MedRxiv, August 12, 2020. https://doi.org/10.1101/2020.08.12.20169359

Kaneko, N. et al. Loss of BcL-6-expressing T follicular helper cells and germinal centers in COVID-19, Cell, 2020. https://doi.org/10.1016/j.cell.2020.08.025

Kang et al. Crystal Structure of SARS-CoV-2 Nucleocapsid Protein RNA Binding Domain Reveals Potential Unique Drug Targeting Sites. Acta Pharmaceutica Sinica B, July 2020. https://doi.org/10.1016/j.apsb.2020.04.009

Kariko et al. Incorporation of Pseudouridine into mRNA Yields Superior Nonimmunogenic Vector with Increased Translational Capacity and Biological Stability. Mol. Ther. 16, 1833- 1840 (2008).

Kemp et al. Neutralising antibodies drive spike mediated SARS-CoV-2 evasion. Infectious Diseases (except HIV/AIDS) MedRxiv. https://doi.org/10.1101/2020.12.05.20241927

Keyaerts, E. et al. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Research, 75:179-187, 2007.

Khan et al. A Pilot Clinical Trial of Recombinant Human Angiotensin-Converting Enzyme 2 in Acute Respiratory Distress Syndrome. Critical Care. September 2017; 21(1): 234. https://doi.org/10.1186/s13054-017-1823-x

Kim et al. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development. eBioMedicine. (2020). https://doi.org/10.1016/j.ebiom.2020.10274

Kirsch, D.G., Diehn, M., Cucinotta, F.A., Weichselbaum, R. Lack of supporting data make the risk of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable. Radiotherapy and Oncology 147:217-220, 2020.

Korainik IJ and KL Tyler, COVID-19: A global threat to the nervous system. In press, 2020.

Konno et al. SARS-CoV-2 ORF3b is a Potent Interferon Antagonist Whose Activity is Further Increased by a Naturally Occurring Elongation Variant. BioRxiv, Mar 12, 2020. https://doi.org/10.1101/2020.05.11.088179

Kopecky-Bromberg et al. Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (Orf) 3b, ORF6, and Nucleocapsid Proteins Function as Interferon Antagonists. Journal of Virology, January 2007, 81(2): 548-557. https://doi.org/10.1128/JVI.01782-06

Korber et al. Spike Mutation Pipeline Reveals the Emergence of a More Transmissible Form of SARS-CoV-2. BioRxiv April 30, 2020. https://doi.org/10.1101/2020.04.29.069054

Kuba et al. A Crucial Role of Angiotensin Converting Enzyme 2 (ACE2) in SARS Coronavirus-Induced Lung Injury. Nature Medicine 2005, 11(8): 875-879. https://www.nature.com/articles/nm1267

Kumar, N et al. Integrative network biology framework elucidates molecular mechanisms of SARS-CoV-2 pathogenesis. iScience, 2020.

Lai A. G., Pasea L., Banerjee A., et al. Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. ResearchGate DOI: 10.13140/RG.2.2.34254.82242 (2020)

Lan, J., Ge, J., Yo, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature published online 30 March 2020. https://doi.org/10.1038/s41586-020-2180-5

Lara, P., Burgos, J., Macias, D. Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment. Clinical and Translational Radiation Oncology 23:27-29 (2020).

Latham, J., Wilson, A. A Proposed Origin for SARS-CoV-2 and the COVID-19 Pandemic. Independent Science News, July 15, 2020.

Laurer et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) from Publicly Reported Confirmed Cases; Estimation and Application. Annals of Internal Medicine, March 10, 2020; 172 (9): 577-582. https://doi.org/10.7326/M20-0504

Lavezzo et al. Suppression of a SARS-CoV-2 Outbreak in the Italian Municipality of Vo’. Nature, April 2020. https://doi.org/10.1038/s41586-020-2488-1

Leask, H. Huge Global Push for RCTs in COVID-19: From Random to Randomized. www.Medscape.com, April 4, 2020.

Le Bert, N. et al., SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature, 2020.

Leclerc et al. What Settings have been Tied to SARS-CoV-2 Transmission Clusters? Wellcome Open Research, 2020, 5:83. https://doi.org/10.12688/wellcomeopenres.15889.1

Leng et al. Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcomes of Patients with COVID-19 Pneumonia. Aging and Disease 2020, 11(2): 216-228.

http://www.aginganddisease.org/EN/10.14336/AD.2020.0228

Leonhardt, D. The Singapore warning. New York Times 16 April, 2020.

Li, R. et al. Substantial Undocumented Infection Facilitates the Rapid Dissemination of Novel Coronavirus (SARS-CoV-2). Science, March 2020, doi: 10.1126/science.abb3221. https://science.sciencemag.org/content/early/2020/03/24/science.abb3221.full

Li, X.C. et al. The Vasoprotective Axes of the Renin-Angiotensin System: Physiological Relevance and Therapeutic Implications in Cardiovascular, Hypertensive, and Kidney Diseases. Pharmacological Research, November 2017, 125(Part A): 21-38. https://www.ncbi.nlm.nih.gov/pubmed/28619367

Li, W., et al. High potency of a bivalent human VH domain in SARS-CoV-2 animal models. Cell, 2020.

Li, Y.C.,Bai, W.Z.,Hashikawa, T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients, J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25728. [Epub ahead of print]

Li, Y., Wang, M. et al. Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study. The Lancet pre-print, March 13, 2020. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3550025

Liang, W., Guan, W., Chen, R. et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncology 21:335-337 (2020).

Lighter et al. Obesity in Patients with Younger than 60 Years is a Risk Factor for COVID-19 Hospital Admission. Clinical Infectious Diseases, April 9, 2020. https://doi.org/10.1093/cid/ciaa415

Lin, L., Fu, G., Chen, S., et al. CT manifestations of coronavirus disease (COVID-19) pneumonia and influenza virus pneumonia: a comparative study. Am J Radiol 216:1-9 (2021). https://doi.org/10.2214/AJR.20.23304

Lipsitch et al. Absolute Humidity and Pandemic Versus Epidemic Influenza. American Journal of Epidemiology, January 2011, 173(2): 127-135. https://doi.org/10.1093/aje/kwq347

Liu, J., et al. Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China. Emerging Infectious Diseases, June 30, 2020. https://doi.org/10.3201/eid2609.201798

Liu, L., et al. Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike. Nature, July 22, 2020. https://doi.org/10.1038/s41586-020-2571-7

Liu, Y., Gayle, A., Wilder-Smith, A., and Rocklöv, J., (2020). The reproductive number of COVID-19 is higher compared to SARS coronavirus. Journal of Travel Medicine. https://doi.org/10.1093/jtm/taaa021

Liu, Y. et al. Viral Dynamics in Mild and Severe Cases of COVID-19. The Lancet Infectious Disease, March 19, 2020. https://doi.org/10.1016/S1473-3099(20)30232-2

Logunov, D. et al. Safety and Immunogenicity of an rAd26 and rAd5 Vector-Based Heterologous Prime-Boost COVID-19 Vaccine in Two Formulations: Two Open, Non-Randomised Phase I/II Studies from Russia. The Lancet, September 4, 2020. https://doi.org/10.1016/S0140-6736(20)31866-3

Lokugamage et al. SARS-CoV-2 is Sensitive to Type I Interferon Pretreatment. BioRxiv. https://doi.org/10.1101/2020.03.07.982264 (2020)

London A.J. and Kimmelman J. Against pandemic research exceptionalism. Science 358:476-477 (2020).

Long et al. Antibody Responses to SARS-CoV-2 in Patients with COVID-19. Nature Medicine, April 29, 2020. https://doi.org/10.1038/s41591-020-0897-1

Long et al. Clinical and Immunological Assessment of Asymptomatic SARS-CoV-2 Infections. Nature Medicine, June 18, 2020. https://doi.org/10.1038/s41591-020-0965-6

Lovren et al. Angiotensin Converting Enzyme-2 Confers Endothelial Protection and Attenuates Atherosclerosis. American Journal of Physiology, October 1, 2008. https://doi.org/10.1152/ajpheart.00331.2008

Luo, J., Rizvi, H., Egger, J.V., et al. Impact of PD-1 blockage on severity of COVID-19 in patients with lung cancer. Cancer Discovery 10:1-8 (2020). https://doi.org/10.1158/2159-8290.CD-20-0596

MacLean et al. Response to “On the origin and continuing evolution of SARS-CoV-2”. http://virological.org/t/response-to-on-the-origin-and-continuing-evolution-of-sars-cov-2/418

Magagnoli, J., Narendran, S., Pereira, F. et al. Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medRxiv preprint doi: https://doi.org/10.1101/2020.04.16.20065902

Maguen, S., Neria, Y., Conoscenti, L.M., Litz, B.T. Depression and prolonged grief in the wake of disasters. In Neria Y, Galea S, Norris FH, eds. 2009. Mental Health and Disasters. New York: Cambridge Univ. Press, pp. 116–30. https://www.cambridge.org/core/books/mental-health-and-disasters/B7260C9227B3D1E44AB59AE4CA7DE1B0

Mancia et al. Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19. New England Journal of Medicine, May 1, 2020. DOI: 10.1056/NEJMoa2006923.

Mann E R et al. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19. Science Immunol., 2020.

Martineau et al. Vitamin D Supplementation to Prevent Acute Respiratory Tract Infections: Systematic Review and Meta-Analysis of Individual Participant Data. BMJ, 2017; 356:i6583.

https://doi.org/10.1136/bmj.i6583

Mateus et al. Selective and Cross-Reactive SARS-CoV-2 T Cell Epitopes in Unexposed Humans. Science, August 4, 2020. https://doi.org/10.1126/science.abd3871

Mathew D et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science, 369:1209, 2020.

Maziarz, R.T. et al., Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial. Biol Blood Marrow Transplant. 2015 Apr;21(4):720-8. doi: 10.1016/j.bbmt.2014.12.025. Epub 2014 Dec 30.

McCarty et al. Nutraceuticals have Potential for Boosting the Type 1 Interferon Response to RNA Viruses Including Influenza and Coronavirus. Progress in Cardiovascular Diseases, February 2020.

https://doi.org/10.1016/j.pcad.2020.02.007

McCray et al. Lethal Infection of K18-hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus. Journal of Virology, 2007; 81: 813-821.

Mehra et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. New England Journal of Medicine, May 1, 2020. DOI: 10.1056/NEJMoa2007621.

Mehra et al. Hydroxychloroquine or Chloroquine with or without a Macrolide for Treatment of COVID-19: A Multinational Registry Analysis. The Lancet, May 22, 2020. https://doi.org/10.1016/S0140-6736(20)31180-6

Mehta V., Goel S., Kabarriti R., et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. cancerdiscovery.aacrjournals.org DOI:10.1158/2159-8290.CD-20-0516 (2020)

Melin et al. Comparative ACE2 Variation and Primate COVID-19 Risk. MedRxiv, April 19, 2020. https://doi.org/10.1101/2020.04.09.034967

Mercado et al. Single-shot Ad26 Vaccine Protects Against SARS-CoV-2 in Rhesus Macaques. Nature 586, 583-588, July 30, 2020. https://doi.org/10.1038/s41586-020-2607-z

Mesin, L. et al. Restricted clonality and limited germinal center reentry characterize memory B cell reactivation by boosting. Cell, 180, 2020. https://doi.org/10.1016/j.cell.2019.11.032

Mikkonen L., Pihlajamaa P., Sahu B., et al. Androgen receptor and androgen-dependent gene expression in lung. Mol Cell Endocrinol 317:14-24 (2020).

Molina et al. No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection. Médecine et Maladies Infectieuses, March 30, 2020. https://doi.org/10.1016/j.medmal.2020.03.006

Monteil et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell, April 24, 2020. https://doi.org/10.1016/S2213-2600(20)30418-5

Moore J.B. and June C.H., Cytokine release syndrome in severe COVID-19. Science 368:473-474 (2020)

Montopoli M, Zumerle S, Vettor R, et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532). Annals of Oncology (2020), doi: https://doi.org/10.1016/j.annonc.2020.04.479

Moseman EA et al., T cell engagement of cross-presenting microglia protects the brain from a nasal viral infection. Science Immunology, 2020.

Mosites et al. Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters - Four U.S. Cities, March 27 - April 15, 2020. Morbidity and Mortality Weekly Report, May 1, 2020; 69(17): 521-522. http://dx.doi.org/10.15585/mmwr.mm6917e1

Mou, H., Raj, V. S., van Kuppeveld, F. J., Rottier, P. J., Haagmans, B. L., and Bosch, B. J. The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. Journal of virology, 87(16), 9379–9383 (2013). https://doi.org/10.1128/JVI.01277-13

Mulligan, et al. Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report. MedRxiv, July 1, 2020. https://doi.org/10.1101/2020.06.30.20142570

Munster et al. ChAdOx1 nCoV-19 Vaccination Prevents SARS-CoV-2 Pneumonia in Rhesus Macaques. BioRxiv, May 13, 2020. https://doi.org/10.1101/2020.05.13.093195

Neal, MM. Fake cures and real law: Analyzing the legal implications of DIY COVID vaccines. The Wake Forest Law Review, 22 September 2020.

Neria, Y., Galea, S., Norris, F.H., eds. Mental Health and Disasters. New York: Cambridge Univ. Press

https://www.cambridge.org/core/books/mental-health-and-disasters/B7260C9227B3D1E44AB59AE4CA7DE1B0

Neria, Y., Nandi, A., Galea, S. 2008. Post-traumatic stress disorder following disasters: a systematic review. Psychol. Med. 38:467–80. https://www.ncbi.nlm.nih.gov/pubmed/17803838

Netea et al. BCG Vaccination Protects Against Viral Infection in Humans Through the Induction of Cytokines Associated with Trained Immunity. Cell Host and Microbe, January 2018, 23(1): P89-100.

https://doi.org/10.1016/j.chom.2017.12.01

Nishiura et al. Closed Environments Facilitate Secondary Transmission of Coronavirus Disease 2019. MedRxiv, April 16, 2020. https://doi.org/10.1101/2020.02.28.20029272

Nguyen, et al. Virus Against Virus: A Potential Treatment for 2019-nCoV (SARS-CoV-2) and other RNA Viruses. Cell Research: 30:189-190, 2020. https://doi.org/10.1038/s41422-020-0290-0

Norris Wind LH. The experience of disaster: trauma, loss, adversities, and community effects. In Neria, Y., Galea, S., Norris, F.H., eds. Mental Health and Disasters. New York: Cambridge University Press. https://www.cambridge.org/core/books/mental-health-and-disasters/B7260C9227B3D1E44AB59AE4CA7DE1B0

O’Dwyer, P. Letter to ECOG-ACRIN Investigators (March 25, 2020). See also http://www.ecog.org/ecoginst/COVID-19_guidance_for_ECOG-ACRIN_studies_20200325.pdf for more recent updates.

Oesterreich et al. Successful Treatment of Advanced Ebola Virus Infection with T-705 (Favipiravir) in a Small Animal Model, Antiviral Research May 2014, 105: 17-25.

https://doi.org/10.1016/j.antiviral.2014.02.014

Offord C. The Surgisphere scandal: What went wrong? The Scientist, October 1, 2020.

Okba et al. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients. Emerging Infectious Diseases, July 2020 early release, 26(9). https://doi.org/10.3201/eid2607.200841

Olena, A. SARS-CoV-2 spike protein shares sequences with a human protein. The Scientist. June 1, 2020.

Olival, K. et al. Host and Viral Traits Predict Zoonotic Spillover from Humans. Nature June 21, 2017, 546: 646-650. https://doi.org/10.1038/nature22975

Ou et al. Characterization of Spike Glycoprotein of SARS-CoV-2 on Virus Entry and its Immune Cross-Reactivity with SARS-CoV. Nature Communications March 27, 2020, 11(1): 1620. doi:10.1038/s41467-020-15562-9

Oxley et al. Large-Vessel Stroke as a Presenting Feature of COVID-19 in Young. The New England Journal of Medicine, April 28, 2020. https://www.nejm.org/doi/full/10.1056/NEJMc2009787

Pairo-Castineira et al. Genetic Mechanisms of Critical Illness in COVID-19. Nature, December 11, 2020. [1]

Pan et al. Viral Load of SARS-CoV-2 in Clinical Samples. Lancet Infectious Diseases, February 24, 2020; 20(4), 411–412. https://doi.org/10.1016/S1473-3099(20)30113-4

Pan H. for the WHO Solidarity Trial Consortium. Repurposed antiviral drugs for COVID-19 - interim WHO SOLIDARITY trial results. https://doi.org/10.1101/2020.10.15.20209817

Patterson et al. Evidence of Exposure to SARS-CoV-2 in Cats and Dogs from Households in Italy. BioRxiv, July 23, 2020. https://doi.org/10.1101/2020.07.21.214346

Pearman et al. Age differences in risk and resilience factors in COVID-19 related stress. The Journals of Gerontology, 2020.

Pierce et al. Immune responses of SARS-CoV-2 infection in hospitalized pediatric and adult patients. Science Translational Medicine, September 21, 2020.

Pino, L., Perez, C., Cardona, A., and Triana, I. Cancer center recommendations to mitigate COVID-19 impact in patients with cancer: low-resource settings version. JCO Global Oncology published at ascopubs.org/journal/go on April 13, 2020. DOI: https://doi.org/10.1200/GO.20.00093

Poh et al. Two Linear Epitopes on the SARS-CoV-2 Spike Protein that Elicit Neutralizing Antibodies in COVID-19 Patients. Nature Communications, June 1, 2020. 11, 2806. https://doi.org/10.1038/s41467-020-16638-

Premkumar L et al. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Science Immunol., 2020.

Puntmann et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19). JAMA Cardiology, July 27, 2020. https://doi.org/10.1001/jamacardio.2020.3557

Qian et al. Indoor Transmission of SARS-CoV-2. MedRxiv, April 16, 2020. https://doi.org/10.1101/2020.04.04.20053058

Qin, Bao et al. Reinfection Could not Occur in SARS-CoV-2 Infected Rhesus Macaques. BioRxiv, https://www.biorxiv.org/content/10.1101/2020.03.13.990226v1

Qing et al. QTY Code Designed Thermostable and Water-Soluble Chimeric Chemokine Receptors with Tunable Ligand Affinity. Proceedings of the National Academy of Science of the United States of America, December 17, 2019, 116(51): 25668-25676, https://doi.org/10.1073/pnas.1909026116.

Rambaut et al. Preliminary Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in the UK Defined by a Novel Set of Spike Mutations. Report by COVID-19 Genomics UK Consortium. https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563

Raptis, C.A., Hammer, M.M., Short, R.G. et al. Chest CT and Coronavirus Disease (COVID-19): A critical review of the literature to date. AJR 215:1-4 (2020). doi.org/10.2214/AJR.20.23202

Regaldo. Some scientists are taking a DIY coronavirus vaccine, and nobody knows if it’s legal or if it works. MIT Technology Review, July 29, 2020.

Reynolds et al. Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19. New England Journal of Medicine, May 1, 2020. DOI: 10.1056/NEJMoa2008975.

Rhodes J., Chan C., Paxson C., Rouse E., Waters M., and Fussell, E. The Impact of Hurricane Katrina on the Mental and Physical Health of Low-Income Parents in New Orleans. Am J Orthopsychiatry. 2010 Apr; 80(2): 237–247. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276074/

Richardson et al. Barcitinib as a Potential Treatment for 2019-nCoV Acute Respiratory Disease. The Lancet, 395(10223): E30-31. https://doi.org/10.1016/S0140-6736(20)30304-4

Rijkers, G. et al. Differences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections. J Infect Dis, July 29, 2020.

Riva, L. et al., Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature, 2020.

Robilotti, E.V., Babady, N.E., Mead, P.A., et al. Determinants of COVID-19 disease severity in patients with cancer. Nature Medicine 26: 1218-1223 (2020). https://doi.org/10.1038/s41591-020-0979-0

Rödel, F., Arenas, M., Ott, O.J., et al. Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence? Strahlentherapie Onkology (2020) https://doi.org/10.1007/s00066-020-01635-7

Rogers TF et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science, 369:956, 2020.

Roschewski, M., Lionakis, M.S., Sharman, J.P., et al. Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Sci. Immunol. 10.1126/sciimmunol.abd0110 (2020)

Ruan et al. Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis of 150 Patients from Wuhan, China. Intensive Care Medicine, April 6, 2020. https://doi.org/10.1007/s00134-020-05991-x

Rubin, G.D., Ryerson, C.J., Haramati, L.B., et al. The role of chest imaging in patient management during the COVID-19 pandemic – A Multinational Consensus Statement from the Fleischner Society. Radiology 296:172-180 (2020). https://doi.org/10.1148.radiol.20.2020.1365

Sadoff et al. Safety and Immunogenicity of the Ad26.COV2.S COVID-19 Vaccine Candidate: Interim Results of a Phase 1/2 , Double-Blinded, Randomized, Placebo-Controlled Trial. MedRxiv, September 25, 2020. https://doi.org/10.1101/2020.09.23.20199604

Sahin et al. Concurrent Human Antibody and TH1 Type T-Cell Responses Elicited by a COVID-19 Vaccine. July 20, 2020. https://doi.org/10.1101/2020.07.17.20140533

Salazar et al. Treatment of COVID-19 Patients with Convalescent Plasma in Houston, Texas. MedRxiv, May 13, 2020. https://doi.org/10.1101/2020.05.08.20095471

Salmon, D.A. and Dudley, M.Z. It is time to get serious about vaccine confidence. The Lancet 396-870-871 (2020)

Salomaa, S., Cardis, E., Simon, D.. Bouffler, S.D., et al. Low dose radiation therapy for COVID-19 pneumonia: Is there any supportive evidence?, International Journal of Radiation Biology, 2020 https://doi.org/10.1080/09553002.2020.1762020

Sánchez-Guijo et al. Adipose-Derived Mesenchymal Stromal Cells for the Treatment of Patients with Severe SARS-CoV-2 Pneumonia Requiring Mechanical Ventilation. A Proof of Concept Study. EClinical Medicine, July 4, 2020. https://doi.org/10.1016/j.eclinm.2020.100454

Sanjuan, R., Nebot, M., Chirico, N., Mansky, L., and Belshaw, R., Viral Mutation Rates, J. Virology, Vol. 84, No. 19 , pgs. 9733-9748 (2010) https://doi.org/10.1128/JVI.00694-10

Santarpia et al. Aerosol and Surface Contamination of SARS-CoV-2 Observed in Quarantine and Isolation Care. Scientific Reports 10, 12732, July 29, 2020. https://doi.org/10.1038/s41598-020-69286-3

Santillana et al. Role of Absolute Humidity on Transmission Rates of the COVID-19 Outbreak. MedRxiv. February 2020. https://doi.org/10.1101/2020.02.12.20022467

Servick, K. and Enserink, M. A mysterious company’s coronavirus papers in top medical journals may be unravelling. doi:10.1126/science.abd1337

Sen et al. Electroceutical Fabric Lowers Zeta Potential and Eradicates Coronavirus Infectivity Upon Contact. ChemRxiv, May 15, 2020. https://doi.org/10.26434/chemrxiv.12307214.v1

Seow et al. Longitudinal Evaluation and Decline of Antibody Responses in SARS-CoV-2 Infection. MedRxiv, July 11, 2020. https://doi.org/10.1101/2020.07.09.20148429

Seto et al. The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus. Advances in Virology 2011. https://doi.org/10.1155/2011/734690

Sharifi, N. and Ryan, C.J. Androgen hazards with COVID-19. Endocrine-Related Cancer 27: E1-E3 (2020).

Sheahan et al. Broad-spectrum Antiviral GS-5734 Inhibits Both Epidemic and Zoonotic Coronaviruses. Science Translational Medicine, June 28, 2017, 9(396). 10.1126/scitranslmed.aal3653

Sheahan et al. An orally bioavailable broad-spectrum antiviral inhibits 1 SARS-CoV-2 and multiple

2 endemic, epidemic and bat coronavirus. bioRxiv: https://doi.org/10.1101/2020.03.19.997890

Shen et al. Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma. Journal of the American Medical Association, March 27, 2020. https://jamanetwork.com/journals/jama/fullarticle/2763983

Shi, J. et al. Susceptibility of Ferrets, Cats, Dogs, and Different Domestic Animals to SARS-Coronavirus-2. BioRxiv, March 31, 2020. https://doi.org/10.1101/2020.03.30.015347

Shi, S. et al. Association of Cardiac Injury with Mortality in Hospitalized Patients with COVID-19 in Wuhan, China. JAMA Cardiology, March 25, 2020.

https://jamanetwork.com/journals/jamacardiology/fullarticle/2763524

Shirato et al. Wild-Type Human Coronaviruses Prefer Cell-Surface TMPRSS2 to Endosomal Cathepsins for Cell Entry. Virology, April 2018, 517: 9-15. https://doi.org/10.1016/j.virol.2017.11.0

Shrock, E. et al. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science, 2020. https://doi.org/10.1126/science.abd4250

Shuman, A.G., Pentz, R.D. Cancer research ethics and COVID-19. The Oncologist 25:458-459 (2020)

Sidaway P. COVID-19 and cancer: what we know so far. Nature Reviews Clinical Oncology. https://doi.org/10.1038/s41571-020-0366-2 Published online 7 April, 2020

Silverman, E., Feuerstein, A., Herper, M. New data on Gilead’s remdesevir, released by accident,show no benefit for coronavirus patients. Company still sees reason for hope. Accessed at statnews.com 23 April, 2020.

Sit et al. Infection of Dogs with SARS-CoV-2. Nature, May 14, 2020. https://doi.org/10.1038/s41586-020-2334-5

Smith et al. Immunogenicity of a DNA Vaccine Candidate for COVID-19. Nature Communications 11, 2601 (2020). https://doi.org/10.1038/s41467-020-16505-0

Society for Maternal Fetal Medicine. Coronavirus (COVID-19) and pregnancy: what maternal fetal medicine subspecialists need to know. 2020. https://www.smfm.org/covid19

Somers, E.C., Eschenauer, G.A., Troost, J.P. et al. Tocilizumab for treatment of mechanically ventilated patients with COVID-19. medRx doi: https://doi.org/10.1101/2020.05.29.20117358.

Song et al. Neuroinvasive Potential of SARS-CoV-2 Revealed in Human Brain Organoid Model. bioRxiv, June 26, 2020. https://doi.org/10.1101/2020.06.25.169946

Sontag, S. Illness as metaphor and AIDS and its metaphors. New York: Picador 2001.

Srinivasan et al. Melatonin in Bacterial and Viral Infections with Focus on Sepsis: A Review. Recent Patents on Endocrine, Metabolic, & Immune Drug Discovery, 2012, 6(1): 30-39.

https://doi.org/10.2174%2F187221412799015317

Stebbing et al. COVID-19: Combining antiviral and anti-inflammatory treatments, 2020. The Lancet, Comment (February 27, 2020)

Steindler, D.A. and Reynolds, B.A. Perspective: Neuroregenerative Nutrition, Adv. Nutr. 2017 8, 546-57; doi: https://doi.org/10.3945/an.117.015388.

Sterne JAC for the WHO Rapid Evidence Appraisal for COVID-19Therapies (REACT) Working Group. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19 - A meta-analysis. JAMA doi:10.1001/jama.2020.17023

Substance Abuse and Mental Health Services Administration: Communicating in a Crisis: Risk Communication Guidelines for Public Officials. SAMHSA Publication No. PEP19-01-01-005. Rockville, MD, Substance Abuse and Mental Health Services Administration, 2019.

https://store.samhsa.gov/product/communicating-crisis-risk-communication-guidelines-public-officials/pep19-01-01-005

Summerfield, J. A. Clinical potential of mannose-binding lectin-replacement therapy. Biochem Soc Transac 31:770, 2003.

Tang, N. et al. Abnormal Coagulation Parameters are Associated with Poor Prognosis in Patients with Novel Coronavirus Pneumonia. Journal of Thrombosis and Haemostasis, February 19, 2020. https://doi.org/10.1111/jth.14768

Tang, X. et al. On the Origin and Continuing Evolution of SARS-CoV-2, National Science Review https://doi.org/10.1093/nsr/nwaa036

te Velthuis et al. Zn2+ Inhibits Coronavirus and Arteririvirus RNA Dependent RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture. Plos Pathogens 6(11), November 2010. https://doi.org/10.1371/journal.ppat.1001176 Biochem Soc Trans 31: 770, 2003.

The American College of Obstetrics and Gynecologists. Practice Advisory: Novel Coronavirus 2019 (COVID-19). https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/03/novel-coronavirus-2019

Tian et al. Potent Binding of 2019 Novel Coronavirus Spike Protein by a SARS Coronavirus-Specific Human Monoclonal Antibody. Emerging Microbes and Infections, February 17, 2020, 9(1): 382-385.

https://doi.org/10.1080/22221751.2020.1729069

Thoms et al. Structural Basis for the Translational Shutdown and Immune Evasion by the Nsp1 Protein of SARS-CoV. BioRxiv, May 18, 2020. https://doi.org/10.1101/2020.05.18.102467

Toubiana et al. Outbreak of Kawasaki Disease in Children During the COVID-19 Pandemic: A Prospective Observational Study in Paris, France. MedRxiv, May 14, 2020. https://doi.org/10.1101/2020.05.10.20097394

Tsoi et al. The SARS-Coronavirus Membrane Protein Induces Apoptosis via Interfering with PDK1-PKB/Akt Signalling. The Biochemical Journal, December 15, 2014. https://doi/org/10.1042/BJ20131461

Ueda, M., Martins, R., Hendrie, P.C. et al. Managing cancer care during the COVID-19 pandemic; Agility and collaboration toward a common goal. JNCCN 18:1-4 (2020).

Umapathi et al. Large Artery Ischaemic Stroke in Severe Acute Respiratory Syndrome (SARS). Journal of Neurology, 2004, 251(10): 1227-1231. doi: 10.1007/s00415-004-0519-8

U.S. Food and Drug Administration. Pooled sample testing and screening testing for COVID-19. Updated 24 August, 2020 (accessed 16 October, 2020).

Valdimarsson et al. Human plasma-derived mannose-binding lectin: A phase 1 safety and pharmacokinetic study, Scandanavian J Immunology 59, 97-102, 2004.

Valitutto et al. Detection of Novel Coronaviruses in Bats in Myanmar. PLOS ONE, April 9, 2020. https://doi.org/10.1371/journal.pone.0230802

Van Doremalen et al. Aerosol and Surface Stability of HCoV-19 (SARS-CoV-2) Compared to SARS-CoV-1. MedRxiv. https://doi.org/10.1101/2020.03.09.20033217.

Verdia-Baguena et al. Coronavirus E Protein Forms Ion Channels with Functionally and Structurally Involved Membrane Lipids. Virology, October 25, 2012; 432(2): 485-494. https://doi.org/10.1016/j.virol.2012.07.005

Verdoni et al. An Outbreak of Severe Kawasaki-like Disease at the Italian Epicentre of the SARS-CoV-2 Epidemic; An Observational Cohort Study. The Lancet, May 13, 2020. https://doi.org/10.1016/S0140-6736(20)31103-X

Vincent et al. Chloroquine is a Potent Inhibitor of SARS Coronavirus Infection and Spread. Virology Journal, 2005. https://virologyj.biomedcentral.com/articles/10.1186/1743-422X-2-69

Vogels et al. SalivaDirect: Simple and Sensitive Molecular Diagnostic Test for SARS-CoV-2 Surveillance. MedRxiv, August 4, 2020. https://doi.org/10.1101/2020.08.03.20167791

de Vrieze. Can a Century-Old TB Vaccine Steel the Immune System Against the New Coronavirus? Science (2020)

https://www.sciencemag.org/news/2020/03/can-century-old-tb-vaccine-steel-immune-system-against-new-coronavirus

Walsh et al. RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study. MedRxiv, August 28, 2020. https://doi.org/10.1101/2020.08.17.20176651

Wang, C. et al. A Human Monoclonal Antibody Blocking SARS-CoV-2 Infection. Nature Communications 11(2251), May 4, 2020. https://doi.org/10.1038/s41467-020-16256-y

Wang, H. et al. SARS Coronavirus Entry into Host Cells Through a Novel Clathrin- and Caveolae-Independent Endocytic Pathway. Nature Cell Research, Feb 2008(2): 290-301. https://www.nature.com/articles/cr200815

Wang, H., Zhang, Y., et al. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell 182(3): P713-721.E9, June 6, 2020. https://doi.org/10.1016/j.cell.2020.06.008

Wang, K. et al. SARS-CoV-2 Invades Host Cells via a Novel Route: CD-147 Spike Protein. BioRxiv, March 14, 2020. https://doi.org/10.1101/2020.03.14.988345

Wang, X. et al. SARS-CoV-2 Infects T Lymphocytes Through its Spike Protein-Mediated Membrane Fusion. Cellular and Molecular Immunology, April 7, 2020. https://doi.org/10.1038/s41423-020-0424-9

Wang, Y. et al. Remdesivir in Adults with Severe COVID-19: A Randomised, Double-Blind, Placebo-Controlled, Multicentre Trial. The Lancet, April 29, 2020. https://doi.org/10.1016/S0140-6736(20)31022-9

Waterhouse, D., Harvey, R., Hurley, P., et al. Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-term Opportunities for Transformation: Findings from an American Society of Clinical Oncology Survey DOI: 10.1200/ OP.20.00275

Welch, D. et al. Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseases, Nature Scientific Reports 8, 2752 (2018). https://www.nature.com/articles/s41598-018-21058-w

Wichmann et al. Autopsy Findings and Venous Thromboembolism in Patients with COVID-19. Annals of Internal Medicine, May 6, 2020. https://doi.org/10.7326/M20-2003

Williams, C. Low dose chest radiation for COVID-19 patients. 27 April, 2020. https://www.winshipcancer.emory.edu

Wise, J. COVID-19: New Coronavirus Variant is Identified in UK. BMJ; 371, December 16, 2020. https://doi.org/10.1136/bmj.m4857

Woelfel et al. Clinical Presentation and Virological Assessment of Hospitalized Cases of Coronavirus Disease 2019 in Travel-Related Cluster. MedRxiv, March 8, 2020. https://doi.org/10.1101/2020.03.05.20030502

Wolff, G et al. A molecular pore spans the double membrane of the coronavirus replication machinery. Science, September 11, 2020. https://doi.org/10.1126/science.abd3629

Wrapp, D., Wang. N. et al. Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. Science 367(6483): 1260-1273. doi: 10.1126/science.abb2507.

Wrapp, D., McLellan, J. et al. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies. Cell, 181, May 28, 2020. https://doi.org/10.1016/j.cell.2020.04.031

Wright, J.L., Alcorn, S., McNutt, T. et al. An integrated program in a pandemic: Johns Hopkins radiation oncology department. Advances in Radiation Oncology. https://doi.org/10.1016/j.adro.2020.03.014

Wu, F. et al. Neutralizing Antibody Responses to SARS-CoV-2 in a COVID-19 Recovered Patient Cohort and their Implications. MedRxiv, April 6, 2020. https://doi.org/10.1101/2020.03.30.20047365

Wu, F.Q. et al. SARS-CoV-2 Titers in Wastewater are Higher than Expected from Clinically Confirmed Cases. MedRxiv, April 7, 2020. https://doi.org/10.1101/2020.04.05.20051540

Wu S., Zheng D., Liu Y. et al. Radiotherapy during a major outbreak of COVID-19 in Wuhan. Advances in Radiation Oncology (2020). https://doi.org/10.1016/j.adro.2020.03.004

Xia, S., et al. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. JAMA August 13, 2020. https://doi.org/10.1001/jama.2020.15543

Xia, S., et al. Safety and immunogenicity of an Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV: A Randomised, Double-Blind, Placebo-Controlled, Phase 1/2 Trial. The Lancet Infectious Diseases, October 15, 2020. https://doi.org/10.1016/S1473-3099(20)30831-8

Xia, X., et al. Extreme Genomic Deficiency in SARS-CoV-2 and Evasion of Host Antiviral Defense. Molecular Biology and Evolution, April 14, 2020. https://doi.org/10.1093/molbev/msaa094

Xia, Y., Jin, R., Xhao, J. et al. Risk of COVID-19 for Patients with Cancer. Lancet Oncology, March 3, 2020 https://doi.org/10.1016/S1470-2045(20)30150-9

Xiao, F., et al. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology, March 3, 2020; 158(6): 1831-1833.e3. https://doi.org/10.1053/j.gastro.2020.02.055

Xiao, T., et al. Isolation and Characterization of 2019-CoV-like Coronavirus from Malayan Pangolins. BioRxiv. https://doi.org/10.1101/2020.02.17.951335

Xu, Xiaoling et al. Effective Treatment of Severe COVID-19 Patients with Tocilizumab. ChinaXiv 202003.00026 (2020)

Yao et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clinical Infectious Diseases, March 9, 2020. https://doi.org/10.1371/journal.ppat.1001176

Yao, H. et al. Patient-derived mutation impact pathogenicity of SARS-CoV-2, MedRxiv, https://doi.org/10.1101/2020.04.14.20060160

Yeramilli, D., Xu, A.J., Gillespie, E.F. et al. Palliative radiotherapy for oncologic emergencies in the setting of COVID-19: Approaches to balancing risks and benefits. Adv Radiation Oncol 2020 MS # D-20-00082R1.

Yoshimoto, FK. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2 or SARS-nCoV), the Cause of COVID-19. The Protein Journal, May 23, 2020. https:doi.org/10.1007/s10930-020-09901-4

You, B., Ravaud, A., Canivet, A. et al. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncology. March 25, 2020. https://doi.org/10/1016/S1470-2045(20)30204-7

Yu, J., Ouyang, W., Chua, M., Xie, C. SARS-CoV-2 Transmission in Patients with Cancer at Tertiary Care Hospital in Wuhan, China. JAMA Oncol [about:blank https://doi.org.10.1001/jamaoncol.2020.0980] 25 March, 2020.

Yuan, M. et al. A Highly Conserved Cryptic Epitope in the Receptor-Binding Domains of SARS-CoV-2 and SARS-CoV, Science 10.1126/science.abb7269 (2020).

Zhang, G. et al. First In-Class Peptide Binder to the SARS-CoV-2 Spike Protein. BioRxiv. (2020). https://doi.org/10.1101/2020.03.19.999318

Zhang, G. et al. Comparative Analysis of Bat Genomes Provides Insight into the Evolution of Flight and Immunity. Science, January 25, 2013. 339(6118): 456-460. https://science.sciencemag.org/content/339/6118/456

Zhang, L., Zhu, F., Xie, L. et al. Clinical characteristics of COVID-19 infected cancer patients: a retrospective case study in three Ann Oncol https://doi.org/10.106j.annonc.2020.03.296 Published online 26 March, 2020.

Zhang, S., et al. QTY Code Enables Design of Detergent-Free Chemokine Receptors that Retain Ligand-Binding Activities. Proceedings of the National Academy of Sciences of the United States of America, August 28, 2018, 115(37): E8652-E8659. https://doi.org/10.1073/pnas.1811031115

Zhang, T., et al. Pangolin Homology Associated with 2019-nCoV. BioRxiv (2020). https://doi.org/10.1101/2020.02.19.950253

Zhang, Y., et al, Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 Years: Report of the Randomized, Double-Blind, and Placebo-Controlled Phase II Clinical Trial. MedRxiv, August 10, 2020. https://doi.org/10.1101/2020.07.31.20161216

Zhavoronkov et al. Potential COVID-2019 3C-Like Protease Inhibitors Designed Using Generative Deep Learning Approaches. ChemRxiv. (2020) https://doi.org/10.26434/chemrxiv.11829102.v2

Zheng, M., Gao, Y., Wang, G. et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cellular and Molecular Immunology (2020). https://doi.org/10.1038/s41423-020-0402-2

Zheng, M., Song, L. Novel Antibody Epitopes Dominate the Antigenicity of Spike Glycoprotein in SARS-CoV-2 Compared to SARS-CoV. Cellular and Molecular Immunology, March 4, 2020, 17: 536-538. https://doi.org/10.1038/s41423-020-0385-z

Zhou, F. et al. Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet, 2020, 395: 1054-1062.

https://doi.org/10.1016/ S0140-6736(20)30566-3

Zhou, P. et al. Contraction of the type I IFN locus and unusual constitutive expression of IFN-α in bats. Proceedings of the National Academy of Sciences, 2016, 113:2696–2701. doi: 10.1073/pnas.1518240113.

Zhou, P. et al. A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature, 579:270-273 (February 3, 2020). https://doi.org/10.1038/s41586-020-2012-7

Zhou, Y., Hou, Y., Shen, J. et al. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov 6, 14 (2020). https://doi.org/10.1038/s41421-020-0153-3

Zhu F., et al. Immunogenicity and Safety of a Recombinant Adenovirus Type-5-Vectored COVID-19 Vaccine in Healthy Adults Aged 18 Years or Older: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. The Lancet, 396(10249): 479-488 (July 20, 2020). https://doi.org/10.1016/S0140-6736(20)31605-6

Zhu, F. et al. Safety, Tolerability, and Immunogenicity of a Recombinant Adenovirus Type-5 Vectored COVID-19 Vaccine: A Dose-Escalation, Open-Label, Non-Randomised, First-in-Human-Trial. The Lancet, 395(10240): 1845-1854 (May 22, 2020). https://doi.org/10.1016/S0140-6736(20)31208-3

Zhu, L. et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-Existing Type 2 Diabetes. Cell Metabolism, May 1, 2020. https://doi.org/10.1016/j.cmet.2020.04.021

Zhu, N. et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England Journal of Medicine, 382: 727-733. (2020). https://doi.org/10.1056/NEJMoa2001017

Ziegler et al. SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and is Enriched in Specific Cell Subsets Across Tissues. Cell, March 17, 2020. http://dx.doi.org/10.2139/ssrn.3555145

Zou et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020 https://doi.org/10.1007/s11684-020-0754-0

Zoufaly, A. et al. Human recombinant soluble ACE2 in severe COVID-19. The Lancet Respiratory Medicine, 2020.

Zunin, Myers. Substance Abuse and Mental Health Service Administration (SAMHSA) https://www.samhsa.gov/dtac/recovering-disasters/phases-disaster